RBC
ELV icon

Ronald Blue & Co’s Elevance Health ELV Stock Holding History

Ronald Blue & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,220
Closed -$200K – 327
2015
Q2 		$200K Buy
+1,220
New +$195K 0.01% 337

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ronald Blue & Co's ELV Position: Q3 2015 in Review

Ronald Blue & Co sold out of Elevance Health (ELV) in Q3 2015, closing a stake of 1,220 shares — an estimated $200K sold.

Ronald Blue & Co first reported a position in ELV in Q2 2015 and held it in 1 quarter. The position peaked at $200K in Q2 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q3 2015.

  • Ronald Blue & Co reported no remaining Elevance Health position as of Q3 2015 after selling out during the quarter.
  • Ronald Blue & Co sold 1,220 Elevance Health shares in Q3 2015, an estimated $200K.
  • Ronald Blue & Co first reported a position in Elevance Health in Q2 2015 and held it in 1 quarter.
  • Ronald Blue & Co's Elevance Health position peaked at $200K in Q2 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q3 2015.

Based on Ronald Blue & Co's 13F filing for Q3 2015, filed 13 Nov 2015.